Lifecycle Biotechnologies Launches Newly Designed CHEM+SLUSH, 0.9% Sodium Chloride

Share Article

CHEM+SLUSH provides the Organ and Tissue Procurement Organizations (OPOs) with a modernized alternative to simplify and enhance the organ and tissue recovery process.

News Image
The CHEM+SLUSH modernizes the current processes used by the industry and was evolved from input and feedback from Recovery Professionals in a collaborative approach to enhance this process and honor the gift of donation.

Lifecycle Biotechnologies, a leading life science tools and services supplier, has announced the innovative redesign of their CHEM+SLUSH, 0.9% Sodium Chloride. Manufactured at Lifecycle’s Chata Biosystems facility, the CHEM+SLUSH utilized Lifecycle’s evolutionary CHEM+POUR Bag technology and provides the Organ and Tissue Procurement Organizations (OPOs) with a modernized alternative to simplify and enhance their organ and tissue recovery process.

“For years, Lifecycle has partnered with numerous Tissue Processors through our unique and evolved CHEM+POUR Bags, meeting the industries chemical, reagent and media needs,” said Aaron Schieving, Director of Sales and Marketing for Lifecycle Biotechnologies. “It is time for us now to turn our attention to the recovery side of the industry to extend our support to the amazing lifesaving and life-enhancing Organ and Tissue Donation process. The CHEM+SLUSH evolved from input and feedback from Recovery Professionals across the industry in a collaborative approach to enhance this process.”

The CHEM+SLUSH is designed to align with the industries needs for the 0.9% Sodium Chloride, or Slush, nearly all OPOs use. The Slush process entails receiving the liquid Sodium Chloride, typically in a one-liter IV style bags and then freezing them to be used at the recovery site. At the time of use, a manual intensive process of breaking the frozen Sodium Chloride into Slush occurs. As a simplified and improved alternative to this process, the CHEM+SLUSH lays flat in the freezer and is stackable, providing a much improved and easier storage capacity; the CHEM+SLUSH can be broken by hand instead of the manual intensive process, allowing the process to be more aseptic, controlled and less labor intensive; the CHEM+SLUSH process also reduces the risk if contamination of the Slush due to eliminating packaging debris, typically resulting from the IV style bag and manually intensive process.

“The CHEM+SLUSH modernize the current processes used by the industry while it also secures the supply chain for the OPOs, as the Slush is typically associated with allocation issues, which plague the industry. We can offer a constant, consistent supply,” said Schieving. “By taking a breakthrough technology like our CHEM+POUR Bags and re-tasking it for this specific usage, we are addressing the urgency of the industry to meet modern needs.” Schieving notes that “Be Relevant” is a core company value and this is a clear demonstration of exactly that.

To learn more about the CHEM+SLUSH and to see it for yourself be sure to visit with the Lifecycle team at the American Association of Tissue Banks (AATB) Quality and Donor Suitability Workshop in Baltimore, MD on the 30th of April through the 2nd of May 2018.

Based in Ft. Worth, TX, Lifecycle Biotechnologies has served the life science industry for 40 years. Lifecycle provides a unique and unmet need for the sterility, packaging, and preparation of leading pharmaceuticals, medical devices, biologics, cell- and tissue-based products, and many other medical products. Lifecycle develops and applies processes for lifesaving and life-enhancing medical products. For more info on Lifecycle Biotechnologies, please visit: http://www.LifecycleBio.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Aaron Schieving
Visit website